A+Science City site

Stockholm 111 57

0 studies enrolling now · 2 studies all time

What they study most

Cardiovascular Disease, Diabetic Nephropathies

Studies at this site

• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy — Completed